New Risk • Jun 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Market cap is less than US$10m (₹830.6m market cap, or US$8.75m). Minor Risk Latest financial reports are more than 6 months old (reported September 2025 fiscal period end). Announcement • May 19
Alkosign Limited to Report Fiscal Year 2026 Results on May 29, 2026 Alkosign Limited announced that they will report fiscal year 2026 results on May 29, 2026 New Risk • Mar 24
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹916.3m (US$9.77m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (50% increase in shares outstanding). Market cap is less than US$10m (₹916.3m market cap, or US$9.77m). Reported Earnings • Nov 15
First half 2026 earnings released: EPS: ₹0.45 (vs ₹3.07 in 1H 2025) First half 2026 results: EPS: ₹0.45 (down from ₹3.07 in 1H 2025). Revenue: ₹264.9m (down 5.0% from 1H 2025). Net income: ₹3.95m (down 88% from 1H 2025). Profit margin: 1.5% (down from 12% in 1H 2025). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 16% per year. Announcement • Nov 04
Alkosign Limited to Report Q2, 2026 Results on Nov 13, 2025 Alkosign Limited announced that they will report Q2, 2026 results on Nov 13, 2025 Reported Earnings • Sep 09
Full year 2025 earnings released: EPS: ₹3.49 (vs ₹0.81 in FY 2024) Full year 2025 results: EPS: ₹3.49 (up from ₹0.81 in FY 2024). Revenue: ₹515.3m (up 44% from FY 2024). Net income: ₹37.7m (up 381% from FY 2024). Profit margin: 7.3% (up from 2.2% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Announcement • Sep 02
Alkosign Limited, Annual General Meeting, Sep 26, 2025 Alkosign Limited, Annual General Meeting, Sep 26, 2025, at 12:00 Indian Standard Time. Location: s no:12a, midc, nr mother dairy, saravali bhiwandi thane mh 421311, India New Risk • Jul 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (50% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₹1.20b market cap, or US$14.0m). Valuation Update With 7 Day Price Move • Jun 30
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹111, the stock trades at a trailing P/E ratio of 31.8x. Average trailing P/E is 22x in the Commercial Services industry in India. Total returns to shareholders of 132% over the past three years. New Risk • Jun 17
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 50% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (50% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₹1.14b market cap, or US$13.3m). Reported Earnings • Jun 02
Full year 2025 earnings released: EPS: ₹5.24 (vs ₹1.22 in FY 2024) Full year 2025 results: EPS: ₹5.24 (up from ₹1.22 in FY 2024). Revenue: ₹518.5m (up 45% from FY 2024). Net income: ₹37.7m (up 381% from FY 2024). Profit margin: 7.3% (up from 2.2% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has only increased by 32% per year, which means it is significantly lagging earnings growth. Announcement • May 20
Alkosign Limited to Report Fiscal Year 2025 Results on May 30, 2025 Alkosign Limited announced that they will report fiscal year 2025 results on May 30, 2025 Valuation Update With 7 Day Price Move • Mar 25
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹92.61, the stock trades at a trailing P/E ratio of 38.2x. Average trailing P/E is 22x in the Commercial Services industry in India. Total returns to shareholders of 105% over the past three years. Valuation Update With 7 Day Price Move • Mar 06
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₹78.31, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 21x in the Commercial Services industry in India. Total returns to shareholders of 69% over the past three years. Reported Earnings • Feb 15
Third quarter 2025 earnings released: EPS: ₹1.30 (vs ₹3.48 loss in 3Q 2024) Third quarter 2025 results: EPS: ₹1.30 (up from ₹3.48 loss in 3Q 2024). Revenue: ₹112.2m (up 55% from 3Q 2024). Net income: ₹9.37m (up ₹34.4m from 3Q 2024). Profit margin: 8.3% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth. New Risk • Jan 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Revenue is less than US$5m (₹423m revenue, or US$4.9m). Market cap is less than US$100m (₹874.2m market cap, or US$10.2m). Announcement • Nov 06
Alkosign Limited to Report Q2, 2025 Results on Nov 13, 2024 Alkosign Limited announced that they will report Q2, 2025 results on Nov 13, 2024 New Risk • Nov 06
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹841.8m (US$10.00m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹841.8m market cap, or US$10.00m). Minor Risk Revenue is less than US$5m (₹357m revenue, or US$4.2m). New Risk • Sep 16
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹831.0m (US$9.91m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹831.0m market cap, or US$9.91m). Minor Risk Revenue is less than US$5m (₹357m revenue, or US$4.3m). Announcement • Aug 30
Alkosign Limited, Annual General Meeting, Sep 27, 2024 Alkosign Limited, Annual General Meeting, Sep 27, 2024, at 11:00 Indian Standard Time. Location: s no:12a, midc, nr mother dairy, saravli, thane, bhiwandi - 521311, maharashtra, thane India Announcement • Aug 03
Alkosign Limited to Report Q1, 2025 Results on Aug 09, 2024 Alkosign Limited announced that they will report Q1, 2025 results on Aug 09, 2024 New Risk • Jun 06
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹826.0m (US$9.89m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹826.0m market cap, or US$9.89m). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Shareholders have been diluted in the past year (32% increase in shares outstanding). Revenue is less than US$5m (₹360m revenue, or US$4.3m). Reported Earnings • Jun 04
Full year 2024 earnings released: EPS: ₹1.22 (vs ₹0.84 loss in FY 2023) Full year 2024 results: EPS: ₹1.22 (up from ₹0.84 loss in FY 2023). Revenue: ₹359.7m (up 68% from FY 2023). Net income: ₹7.84m (up ₹12.4m from FY 2023). Profit margin: 2.2% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Announcement • Jun 01
Alkosign Limited Recommends Dividend for the Financial Year 2023-24 Alkosign Limited Recommended Dividend @1% (INR 0.10 per equity share) for the financial year 2023-24 subject to approval of shareholders at the upcoming Annual General meeting of company. Valuation Update With 7 Day Price Move • May 30
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₹141, the stock trades at a trailing P/E ratio of 17x. Average trailing P/E is 32x in the Commercial Services industry in India. Total returns to shareholders of 72% over the past year. New Risk • May 28
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Share price has been volatile over the past 3 months (8.0% average weekly change). Shareholders have been diluted in the past year (32% increase in shares outstanding). Revenue is less than US$5m (₹335m revenue, or US$4.0m). Market cap is less than US$100m (₹1.16b market cap, or US$14.0m). Announcement • May 19
Alkosign Limited to Report Fiscal Year 2024 Results on May 30, 2024 Alkosign Limited announced that they will report fiscal year 2024 results on May 30, 2024 Valuation Update With 7 Day Price Move • Mar 13
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₹156, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 28x in the Commercial Services industry in India. Total returns to shareholders of 100% over the past year. Valuation Update With 7 Day Price Move • Feb 14
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹189, the stock trades at a trailing P/E ratio of 22.8x. Average trailing P/E is 30x in the Commercial Services industry in India. Total returns to shareholders of 152% over the past year. Valuation Update With 7 Day Price Move • Nov 17
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₹194, the stock trades at a trailing P/E ratio of 23.4x. Average trailing P/E is 31x in the Commercial Services industry in India. Total returns to shareholders of 163% over the past year. Reported Earnings • Nov 15
First half 2024 earnings released: EPS: ₹10.31 (vs ₹1.16 loss in 1H 2023) First half 2024 results: EPS: ₹10.31 (up from ₹1.16 loss in 1H 2023). Revenue: ₹212.5m (up 133% from 1H 2023). Net income: ₹58.0m (up ₹64.3m from 1H 2023). Profit margin: 27% (up from net loss in 1H 2023). The move to profitability was driven by higher revenue. Announcement • Nov 04
Alkosign Limited to Report Q2, 2024 Results on Nov 10, 2023 Alkosign Limited announced that they will report Q2, 2024 results on Nov 10, 2023 Announcement • Sep 28
Alkosign Limited Announces Executive Changes Alkosign Limited at its AGM held on September 26, 2023, announced change in designation of Mr. Shrenik Kamlesh Shah from Non-Executive Director to Whole Time Director and Fixation of Remuneration and change in designation of Mr. Akshay Narendra Shah, from Whole Time Director to Non-Executive Director. Announcement • Sep 13
Alkosign Limited announced that it has received INR 162.75 million in funding from Aegis Investment Fund On September 12, 2023, Alkosign Limited closed the transaction. the company announced that the transaction has been approved by the shareholders and allotted 1,750,000 shares to the respective investors. Announcement • Aug 30
Alkosign Limited, Annual General Meeting, Sep 26, 2023 Alkosign Limited, Annual General Meeting, Sep 26, 2023, at 11:00 Indian Standard Time. Location: S NO:12A, MIDC, NR MOTHER DAIRY, SARAVLI BHIWANDI THANE MH 421311 Thane India Agenda: To consider ADOPTION OF ANNUAL ACCOUNTS: to discuss RE-APPOINTMENT OF MR. AKSHAY NARENDRA SHAH; to discuss INCREASing THE REMUNERATION OF MR. SAMIR NARENDRA SHAH; and to discuss CHANGE IN DESIGNATION OF MR. SHRENIK KAMLESH SHAH. New Risk • Aug 09
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 32% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Shareholders have been diluted in the past year (32% increase in shares outstanding). Revenue is less than US$5m (₹214m revenue, or US$2.6m). Market cap is less than US$100m (₹874.7m market cap, or US$10.6m). New Risk • Aug 09
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 32% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Shareholders have been diluted in the past year (32% increase in shares outstanding). Revenue is less than US$5m (₹214m revenue, or US$2.6m). Market cap is less than US$100m (₹874.7m market cap, or US$10.6m). Announcement • Aug 03
Alkosign Limited announced that it expects to receive funding from Aegis Investment Fund and other investors Alkosign Limited announced that a private placement of up to 17,50,000 shares on August 2, 2023. The transaction will include participation from new investors Aegis Investment Fund, Monica Sancheti, Mihir Dhirajlal Savla, Sanjay Sancheti and Narayanan Kutty Kizhepata. The transaction was approved by the board of directors of the company and subject to the approval of the shareholders of the Company and such regulatory/statutory approvals as may be required. The company will issue shares through preferential allotment. Reported Earnings • Jun 03
Full year 2023 earnings released: ₹0.84 loss per share (vs ₹4.35 loss in FY 2022) Full year 2023 results: ₹0.84 loss per share (improved from ₹4.35 loss in FY 2022). Revenue: ₹216.3m (up 113% from FY 2022). Net loss: ₹4.56m (loss narrowed 67% from FY 2022). Board Change • May 30
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 4 non-independent directors. Non-executive Independent Director Parshva Doshi was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Board Change • Apr 25
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 4 non-independent directors. Non-executive Independent Director Parshva Doshi was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Announcement • Jan 25
Alkosign Limited Starts Luggage Manufacturing Unit with Trial Run and the Company Will Start Full Pledge Production by February 15, 2023 Alkosign Limited started luggage manufacturing unit with trial run. Further Company will start full pledge production by February 15, 2023. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Non-executive Independent Director Parshva Doshi was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Nov 05
Alkosign Limited to Report First Half, 2023 Results on Nov 14, 2022 Alkosign Limited announced that they will report first half, 2023 results on Nov 14, 2022 Board Change • Sep 10
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Non-executive Independent Director Parshva Doshi was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Sep 09
Alkosign Limited Announces Resignation of Priya Navin Kapoor as Independent Director Alkosign Limited announced that Mrs. Priya Navin Kapoor, Independent Director has vide his resignation letter dated September 08, 2022, resigned from the Board of the company with immediate effect, on account to increasing professional commitments and time constraints. Announcement • Aug 30
Alkosign Limited, Annual General Meeting, Sep 24, 2022 Alkosign Limited, Annual General Meeting, Sep 24, 2022, at 11:00 Indian Standard Time. Location: S NO: l2,A, MIDC, NR Mother Dairy, Saravli Bhiwandi Thane Thane India Announcement • Jun 27
Alkosign Limited Appoints Ajay Prahlad Vishwakarma as Chief Financial Officer Alkosign Limited at its board meeting held on June 25, 2022, approved the appointment of Mr. Ajay Prahlad Vishwakarma as Chief Financial Officer of company, effective June 25, 2022. Announcement • Jun 16
Alkosign Limited Announces Resignation of Poorvi Gattani as Company Secretary / Compliance Officer Alkosign Limited inform that Ms. Poorvi Gattani, has given the resignation from the post of Company Secretary & Compliance officer of Company vide her resignation letter as received on mailed dated 14-06-2022 due to Pre-occupation and time constraints for the said position. The Company has accepted this resignation and she will be relieved from her duties with effect from closing office hours on 14" June 2022. It is further informed that there is no other material reason for the resignation other than the reason mentioned above. Announcement • Jun 10
Alkosign Limited Announces Resignation of Pratiksha Naik as Chief Financial Officer, Effective June 11, 2022 Alkosign Limited announced that Mrs. Pratiksha Naik, Chief Financial officer has given the resignation from the post of Chief Financial Officer (CFO) of the Company his resignation letter as received on mailed dated June 9, 2022, due to health issues and time constraints for the said position. The Company has accepted these resignation and she will be relieved from her duties with effect from closing office hours on June 11, 2022. It is also further informed that there is no other material reason for the resignation other than the reason mentioned above. Announcement • May 20
Alkosign Limited to Report Fiscal Year 2022 Results on May 27, 2022 Alkosign Limited announced that they will report fiscal year 2022 results on May 27, 2022 Announcement • Feb 02
Alkosign Limited has completed an IPO in the amount of INR 121.5 million. Alkosign Limited has completed an IPO in the amount of INR 121.5 million.
Security Name: Equity Shares
Security Type: Common Stock
Securities Offered: 1,419,000
Price\Range: INR 45
Discount Per Security: INR 3.3615
Security Name: Equity Shares
Security Type: Common Stock
Securities Offered: 1,281,000
Price\Range: INR 45
Discount Per Security: INR 3.3615
Transaction Features: Regulation S 